XBI icon

SPDR S&P Biotech ETF

739 hedge funds and large institutions have $8.01B invested in SPDR S&P Biotech ETF in 2023 Q4 according to their latest regulatory filings, with 142 funds opening new positions, 170 increasing their positions, 269 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

7.05% less ownership

Funds ownership: 117.47%110.43% (-7%)

37% less repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 269

38% less call options, than puts

Call options by funds: $2.01B | Put options by funds: $3.26B

Holders
739
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
23
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.01B
Puts
$3.26B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
551
$217K
552
$217K
553
$217K
554
$215K
555
$214K
556
$211K
557
$210K
558
$209K
559
$208K
560
$207K
561
$207K
562
$206K
563
$205K
564
$203K
565
$203K
566
$202K
567
$202K
568
$201K
569
$201K
570
$198K
571
$183K
572
$179K
573
$174K
574
$174K
575
$173K